Advertisement

Topics

Companies Related to "Agile Therapeutics Resubmits Drug Application Transdermal Dose Contraceptive" [Most Relevant Company Matches] RSS

17:04 EDT 15th June 2019 | BioPortfolio

Here are the most relevant search results for "Agile Therapeutics Resubmits Drug Application Transdermal Dose Contraceptive" found in our extensive corporate database of over 50,000 company records.

Showing "Agile Therapeutics Resubmits Drug Application Transdermal Dose Contraceptive" Companies 1–25 of 5,800+

Extremely Relevant

Agile Therapeutics, Inc

Agile Therapeutics, Inc. is a pharmaceutical product development company founded in 1997 based on developing novel pharmaceutical products utilizing its proprietary transdermal drug delivery technology. The company's lead product is a second generation contraceptive patch, currently in phase II clinical testing. Agile's technology is making the trusted oral contraceptive hormones, levonorgestrel a...


Agile Therapeutics, Inc.

Agile Therapeutics is a pharmaceutical development company specializing in women’s healthcare products, with an initial focus on developing safer, more convenient methods of hormonal contraception. In addition to Agile’s lead, advanced-stage program to develop AG200-15, the Company also is developing a low-dose, progestin-only contraceptive patch, ...

Relevant

Transdermal Delivery Solutions Corporation

TDSC is committed to advancing the science of transdermal drug delivery using its patented spray-on delivery system platform. TDSC’s proprietary system enables a much larger number of medications to be delivered directly through the skin, for systemic or localized application, utilizing its rapid acting, patchless, spray-on technology. TDSC’s tec...


Prescription Dispensing Laboratories

Prescription Dispensing Laboratories announces a major discovery related to the use of calcium channel blockers for the noninvasive, topically applied transdermal treatment of Peyronie's Disease, Dupuytren's Contracture, Plantar Fibromatosis and related connective tissue disorders worldwide patents are pending). Accept no imitations. Transdermal verapamil is available only from PDLABS.A comparison...

Echo Therapeutics, Inc.

Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for use in hospital critical care units and for patients with diabetes. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for transdermal drug delivery of a wide range of novel topical reformulations of widely...

Altea Therapeutics Corporation

Altea Therapeutics is a privately held clinical-stage pharmaceutical company with a proprietary platform technology broadly applicable to the bolus or sustained transdermal delivery of biological drugs (proteins and carbohydrates) that otherwise would be administered by needle injection or infusion. The Company's PassPort® Transdermal Delivery System al...

Teikoku Pharma USA, Inc.

Teikoku Pharma USA, Inc., a wholly-owned subsidiary of Teikoku Seiyaku Co., Ltd. that is a leading supplier of the topical analgesic transdermal patch, Lidoderm®, in the world, is a specialty pharmaceutical company that develops and manufactures enhanced pharmaceutical products with its transdermal drug delivery technology. Teikoku focuses its efforts o...

Transdermal Delivery Solutions Corp.

TDSC is committed to advancing the science of transdermal drug delivery using its patented spray-on delivery system. TDSC’s proprietary system enables medications to be delivered directly through the skin, for systemic or localized application, utilizing its rapid acting, patchless, spray-on technology. The company’s technology is flexible enough...

Noven Pharmaceuticals

Noven Pharmaceuticals, Inc. is a leader in developing and manufacturing transdermal and transoral drug delivery systems.These systems utilize an adhesive patch containing medication which, when adhered to the skin or the mucosa of the oral cavity, allows the delivery of drugs across the tissues and into the bloodstream over an extended period of time. Noven has developed and patented thin, solid s...

Mylan Laboratories

Mylan is a global pharmaceutical company with market leading positions in generic pharmaceuticals, transdermal technology and unit dose packaged products. We focus on providing an extensive line of affordable, high quality prescription drugs in traditional and innovative dosage forms, and we enjoy a well-deserved reputation for scientific expertise in creating difficult-to-formulate and high-barri...

Bespak Europe

Bespak, founded more than 40 years ago, has established a reputation as a leading supplier of drug delivery technologies and services to the pharmaceutical and biotechnology industries.The company’s comprehensive capabilities have enabled it to develop proprietary drug delivery devices and technologies, many protected by worldwide patents. These include pressurised metered dose inhalers and actu...

Sontra Medical Corporation

Sontra Medical Corporation is a technology leader in transdermal science. Sontra's SonoPrep ultrasound-mediated skin permeation technology combined with technical competencies in transdermal drug formulation, delivery systems and biosensors is creating a new paradigm in transdermal drug delivery and diagnosis. The SonoPrep technology is being developed for several billion dollar market opportuniti...

BioChemics, Inc.

BioChemics is a pharmaceutical company that has developed novel topical and transdermal drug delivery systems that for the first time may allow a portfolio of previously transdermally undeliverable drugs to be efficiently delivered through the skin. The drug delivery technology called VALE® (Vaso-active Lipid Encapsulated) may allow many drugs to be re-...

BIND Therapeutics and Navidea Biopharmaceuticals

BIND Therapeutics is a clinical-stage nanomedicine platform company developing a pipeline of Accurins™, its novel targeted therapeutics designed to increase the concentration and duration of therapeutic payloads at disease sites while reducing exposure to healthy tissue. BIND is leveraging its Medicinal Nanoengineering® platform to develop a pipeli...

Yaupon Therapeutics, Inc.

Yaupon Therapeutics, a privately held, specialty pharmaceutical company, is developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). Based upon results of a recently completed trial, Yaupon intends to file a new drug application (...

Glide Pharma

Glide Pharma is a specialty pharmaceutical company focused on the easy, safe and convenient administration of solid dose formulations of therapeutics and vaccines. The company has a range of in-house and partnered programmes based on its proprietary needle-free solid dose injector, the Glide SDI(R).

Vyteris

Vyteris was organized in November 2000 as a spinout of the Transdermal Systems unit of Becton Dickinson and Company ("BD"). Becton Dickinson created Transdermal Systems just prior to 1990 and invested 10 years in the technology Headquartered in Fair Lawn, New Jersey, Vyteris occupies 27,000 square feet of space devoted to research, development and manufacturing of transdermal medication delivery p...

BioSante Pharmaceuticals, Inc.

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante’s lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol...

TransOral Pharmaceuticals, Inc

TransOral Pharmaceuticals, Inc., is a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs. The Company's initial proprietary technology is being employed to accelerate efficacy and reduce drug dose in the development of therapeutics for the treatment of migraine and insomnia.

SCT Spinal Cord Therapeutics GmbH

SCT Spinal Cord Therapeutics GmbH stands for pioneering the therapy of acute and chronic Spinal Cord Injuries (SCI) with its proprietary technology platform: the Regeneration Promoting Treatment (RPT). As first application of RPT SCT Spinal Cord Therapeutics GmbH is focusing on the clinical development of the Orphan Drug Cordaneurin for the treatment of acute SCI.

Amarillo Biosciences Incorporated

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral warts in HIV+ patients and chronic cough in idiopathic pulmonary fibrosis. Low-dose oral interferon is Fundamentally Different from high dose injectable interferon. In this site, we will show the fun...

Enspiral Discovery Ltd

Enspiral Discovery is located in the South Cambridgeshire/Hertfordshire area of the UK and operates through its director and principal consultant, Dr David Morley.How we workWe believe that new computational methods for drug discovery are best developed and validated 'in situ' against live discovery project data. This requires a hands-on, agile combination of scientific research and software engin...

Agile Software Corporation

Agile Software Corporation (NASDAQ: AGIL) helps companies drive profits, accelerate innovation, reduce costs, and ensure regulatory compliance throughout the product lifecycle. With a broad suite of enterprise-class PLM solutions, time-to-value focused implementations, and a unique Guaranteed Business Results program, Agile helps companies get the most from their products. Small and medium enterpr...

Neos Therapeutics, Inc.

Neos Therapeutics Inc. is a specialty pharmaceutical company focused on the development, manufacture and sale of FDA approved drug products which utilize the Company’s proprietary delivery technologies. Neos’ drug products are being developed using the Dynamic Time Release Suspension® (DTRS®) and Rapidly Disintegrating Ionic Masking™ (RDIMâ...

Cynapsus Therapeutics Inc.

Cynapsus is a specialty pharmaceutical company developing a sublingual thin filmstrip for the acute rescue of OFF motor symptoms of Parkinson’s disease. Cynapsus’ drug candidate, APL-130277, is an easy-to-use, fast-acting formulation of apomorphine, which is the only approved drug (in the United States, Europe, Japan and other countries) to rescue ...


More From BioPortfolio on "Agile Therapeutics Resubmits Drug Application Transdermal Dose Contraceptive"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks